Article | August 5, 2021

The Cell & Gene Talent Crunch: Attracting Top-Notch Employees In A Competitive Landscape

Source: Cytiva

By Cytiva

iStock-1242453956-lab-development-scientists-research

Talent and training programs can make a big difference in a molecule’s progress to commercialization, yet in the biopharmaceutical industry, talent is in short supply.

For emerging biopharma companies which may lack reach and resources, understanding how to develop, attract, and retain an advanced therapy, development, manufacturing, and clinical workforce is especially critical.

Michael Mehler, the senior clinical development manager for cell therapy oncology at GlaxoSmithKline, one of the largest pharmaceutical companies in the world, has observed over time how even one small batch with an error can negatively affect patients and cost a company its reputation and millions of dollars.

Mehler shares what it takes to identify and draw a trained workforce to your doorstep for both small and large pharmaceutical organizations.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: